During the past decade, Second MHAT - Sofia AD conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Second MHAT - Sofia AD" #1 sponsor was "Celgene" with 5 trials, followed by "Takeda" with 2 trials sponsored, "Cinclus Pharma AG" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Second MHAT - Sofia AD" #1 collaborator was "Parexel" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Second MHAT - Sofia AD" are "Crohn Disease" (5 trials), "Colitis, Ulcerative" (2 trials), "Crohn's Disease" (2 trials), "Atrial Fibrillation" (1 trials) and "Erosive Esophagitis" (1 trials). Many other conditions were trialed in "Second MHAT - Sofia AD" in a lesser frequency.

Most popular intervention types in "Second MHAT - Sofia AD" are "Drug" (10 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Ozanimod" (3 trials), "GED-0301" (2 trials), "Adalimumab (40 mg)" (1 trials) and "Edoxaban" (1 trials). Other intervention names were less common.

The vast majority of trials in "Second MHAT - Sofia AD" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Second MHAT - Sofia AD". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Second MHAT - Sofia AD, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Second MHAT - Sofia AD, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".